Hepatitis C virus (HCV) infects an estimated 170 million persons worldwide and thus
represents a viral pandemic, one that is five times as widespread as infection with the …

Introduction of effective combined antiretroviral therapy has made HIV infection a chronic
illness. Substantial reductions in the number of AIDS-related deaths have been …

Importance Patients co-infected with human immunodeficiency virus (HIV) and hepatitis C
virus (HCV) are at high risk for liver disease progression. However, interferon-based …

Background An increasing proportion of deaths among human immunodeficiency virus (HIV)–
infected persons with access to combination antiretroviral therapy (cART) are due to …

Studies have shown that rates of liver disease are higher in persons who are coinfected with
human immunodeficiency virus (HIV) and hepatitis C virus (HCV) than they are in persons …

The natural history of hepatitis C virus (HCV) infection in human immunodeficiency virus
(HIV)‐infected patients has never been studied according to the concept of liver fibrosis …

Highly active antiretroviral therapy has decreased human immunodeficiency virus (HIV)-
associated mortality; other comorbidities, such as chronic liver disease, are assuming …

Objectives: To estimate stage-specific transition probabilities in individuals coinfected with
HIV and hepatitis C virus (HCV), to examine the effect of covariates on these rates, and to …

Soon after non-A, non-B hepatitis was recognized and a decade and a half before hepatitis
C virus (HCV) was discovered, it was apparent that acute hepatitis after blood transfusion …

ContextTreatment of chronic hepatitis C virus (HCV) infection in human immunodeficiency
virus (HIV)–infected patients is a growing concern. Most data on the virologic efficacy and …